Somatropin (Genotropin)
Overview
Somatropin is recombinant human growth hormone (rhGH) consisting of 191 amino acids identical in sequence to endogenous pituitary growth hormone. It binds to growth hormone receptors on target tissues to stimulate linear growth, protein synthesis, lipolysis, and carbohydrate metabolism.
Mechanism of Action
Genotropin is one of several branded formulations of somatropin approved for multiple indications including pediatric growth hormone deficiency, Turner syndrome, and adult growth hormone deficiency.
Research Summary & Key Findings
FDA approval was granted in 1995 for pediatric growth hormone deficiency and subsequently expanded to include additional indications based on pivotal trials demonstrating improved height velocity in children and body composition benefits in adults. Long-term safety data spanning decades support its efficacy and tolerability profile across diverse populations. Genotropin remains a widely used first-line treatment for approved growth disorders.
Clinical Status
Somatropin (Genotropin) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.
Administration Routes
References
Primary literature
- PubMed — "Somatropin"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "Somatropin"
Registered interventional and observational studies, including status and phase.
- PubChem — "Somatropin"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Hormone
CJC-1295
In Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that binds to albumin, ...
View detailsIpamorelin
In Clinical TrialsA highly selective growth hormone secretagogue that acts on ghrelin/GHS receptors in the pituitary gland to stimulate GH...
View detailsSermorelin
FDA ApprovedA synthetic 29-amino acid analog of GHRH representing the shortest fully functional fragment of the native 44-amino acid...
View detailsTesamorelin (Egrifta)
FDA ApprovedA synthetic GHRH analog consisting of the 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification...
View detailsStart Your Consultation
Get an AI-proposed Somatropin (Genotropin) protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Somatropin (Genotropin).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.